本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Profound Medical Corp.

5.67
+0.14002.53%
成交量:1.45萬
成交額:8.21萬
市值:1.70億
市盈率:-4.65
高:5.81
開:5.51
低:5.51
收:5.53
資料載入中...
2021/02/09

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/08

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/05

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/11/05

財報披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/07/15

[補充]招股説明書

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2020/05/20

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2020/05/07

財報披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/04/30

超過5%披露

Statement of acquisition of beneficial ownership by individuals
2020/03/10

超過5%披露

Statement of acquisition of beneficial ownership by individuals
2020/03/03

年度報告

Registration statement [Section 12] or Annual Report [Section 13(a), 15(d)]
2020/03/03

財報披露

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/26

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/13

超過5%披露

Statement of acquisition of beneficial ownership by individuals
2020/02/12

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/07

超過5%披露

Statement of acquisition of beneficial ownership by individuals
2020/02/04

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/28

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/27

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/22

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/22

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]